Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn's Disease

The risk of relapse after anti-tumour necrosis factor [TNF] therapy discontinuation in Crohn's disease patients with perianal fistulas [pCD] is unclear. We aimed to assess this risk.A systematic literature search was conducted to identify cohort studies on the incidence of relapse following ant...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Huinink Sebastiaan Ten Bokkel
Thomassen Doranne
Steyerberg Ewout W
Pauwels Renske W M
Casanova Maria J
Mak Joyce W.Y
Molnár Tamás
Lobo Alan J.
Seidelin Jacob B.
Amiot Aurelien
D’Haens Geert
Rivière Pauline
Guidi Luisa
Bor Renáta
Lin Wei-Chen
et al
Dokumentumtípus: Cikk
Megjelent: 2024
Sorozat:JOURNAL OF CROHNS & COLITIS 18 No. 1
Tárgyszavak:
doi:10.1093/ecco-jcc/jjad118

mtmt:34133671
Online Access:http://publicatio.bibl.u-szeged.hu/28220

Hasonló tételek